» Articles » PMID: 22411135

Type 2 Diabetes Mellitus Worsens Arterial Stiffness in Hypertensive Patients Through Endothelial Dysfunction

Overview
Journal Diabetologia
Specialty Endocrinology
Date 2012 Mar 14
PMID 22411135
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Aims/hypothesis: Endothelium-derived factors are thought to be physiological modulators of large artery stiffness. The aim of the study was to investigate whether endothelial function could be a determinant of arterial stiffness in essential hypertensive patients, in relation with the concomitant presence of type 2 diabetes mellitus.

Methods: The study included 341 participants (84 hypertensive patients with and 175 without type 2 diabetes mellitus, 82 matched controls). Brachial artery endothelium-dependent flow-mediated dilation (FMD) was determined by high-resolution ultrasound and computerised edge detection system. Applanation tonometry was used to measure carotid-femoral pulse wave velocity (PWV).

Results: Hypertensive patients with diabetes had higher PWV (10.1 ± 2.3 m/s vs 8.6 ± 1.4 m/s, p < 0.001) and lower FMD (3.51 ± 2.07 vs 5.16 ± 2.96%, p < 0.001) than non-diabetic hypertensive patients, who showed impaired vascular function when compared with healthy participants (7.9 ± 1.6 m/s and 6.68 ± 3.67%). FMD was significantly and negatively correlated to PWV only in hypertensive diabetic patients (r = -0.456, p < 0.001), but not in hypertensive normoglycaemic patients (r = -0.088, p = 0.248) or in healthy participants (r = 0.008, p = 0.946). Multivariate analysis demonstrated that, in the diabetic group, FMD remained an independent predictor of PWV after adjustment for confounders (r(2) = 0.083, p = 0.003). Subgroup analysis performed in non-diabetic hypertensive patients revealed that neither obesity nor the metabolic syndrome affected the relationship between FMD and PWV.

Conclusions/interpretation: Endothelial dysfunction is a determinant of aortic stiffness in hypertensive diabetic patients but not in hypertensive patients without diabetes. These results suggest that type 2 diabetes mellitus on top of hypertension might worsen arterial compliance by endothelium-related mechanisms.

Citing Articles

Aortic Stiffness Measured by Carotid Femoral-Pulse Wave Velocity at Different Stages of Normal Glucose, Prediabetes, and Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Liang X, Li D, Wang Z, Cheng Y, Mou K, Ye C Rev Cardiovasc Med. 2024; 25(9):339.

PMID: 39355589 PMC: 11440398. DOI: 10.31083/j.rcm2509339.


Lack of Association between Serum Chitotriosidase Activity and Arterial Stiffness in Type 2 Diabetes without Cardiovascular Complications.

DOnofrio L, Amendolara R, Mignogna C, Leto G, Tartaglione L, Mazzaferro S Int J Mol Sci. 2023; 24(21).

PMID: 37958794 PMC: 10648693. DOI: 10.3390/ijms242115809.


Role and mechanisms of SGLT-2 inhibitors in the treatment of diabetic kidney disease.

Dai Z, Chen J, Zou R, Liang X, Tang J, Yao C Front Immunol. 2023; 14:1213473.

PMID: 37809091 PMC: 10552262. DOI: 10.3389/fimmu.2023.1213473.


Effects of concurrent aerobic and resistance training on vascular health in type 2 diabetes: a systematic review and meta-analysis.

Chen S, Zhou K, Shang H, Du M, Wu L, Chen Y Front Endocrinol (Lausanne). 2023; 14:1216962.

PMID: 37780628 PMC: 10534066. DOI: 10.3389/fendo.2023.1216962.


A six-month low-carbohydrate diet high in fat does not adversely affect endothelial function or markers of low-grade inflammation in patients with type 2 diabetes: an open-label randomized controlled trial.

Gram-Kampmann E, Olesen T, Hansen C, Hugger M, Jensen J, Handberg A Cardiovasc Diabetol. 2023; 22(1):212.

PMID: 37592243 PMC: 10436534. DOI: 10.1186/s12933-023-01956-8.


References
1.
Thijssen D, Black M, Pyke K, Padilla J, Atkinson G, Harris R . Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol. 2010; 300(1):H2-12. PMC: 3023245. DOI: 10.1152/ajpheart.00471.2010. View

2.
Taddei S, Virdis A, Ghiadoni L, Sudano I, Salvetti A . Effects of antihypertensive drugs on endothelial dysfunction: clinical implications. Drugs. 2002; 62(2):265-84. DOI: 10.2165/00003495-200262020-00003. View

3.
Plantinga Y, Ghiadoni L, Magagna A, Giannarelli C, Penno G, Pucci L . Peripheral wave reflection and endothelial function in untreated essential hypertensive patients with and without the metabolic syndrome. J Hypertens. 2008; 26(6):1216-22. DOI: 10.1097/HJH.0b013e3282fa7158. View

4.
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G . 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007; 25(6):1105-87. DOI: 10.1097/HJH.0b013e3281fc975a. View

5.
Taddei S, Virdis A, Ghiadoni L, Sudano I, Salvetti A . Endothelial dysfunction in hypertension. J Cardiovasc Pharmacol. 2002; 38 Suppl 2:S11-4. DOI: 10.1097/00005344-200111002-00004. View